ROCHESTER, N.Y.--(BUSINESS WIRE)--Carestream Health has received an approval letter from the U.S. Food and Drug Administration (FDA) for its high-resolution computed radiography (CR) system for mammography. Once the FDA approves the final product labeling, Carestream Health can immediately begin commercial distribution of this innovative CR system for mammography in the U.S.
